The authors have previously developed a logistic regression equation to predict the odds
that a human T-cell lymphotropic virus type 1 (HTLV-1)-infected individual of specified …

The main pathological feature of human T-lymphotropic virus type I (HTLV-1)-associated
myelopathy/tropical spastic paraparesis (HAWTSP) is chronic inflammation of the spinal …

Human T-cell lymphotropic virus type-1 (HTLV-1)-associated myelopathy/tropical spastic
paraparesis (HAM/TSP) is chronic inflammatory disease of the spinal cord characterized by …

HTLV-I Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) is a chronic
degenerative disease mainly affecting the spinal cord. The pathogenesis of HAM/TSP is …

Cyclosporine for the Treatment of HTLV-1-Induced HAM/TSP: An... : Medicine Cyclosporine for
the Treatment of HTLV-1-Induced HAM/TSP: An Experience from a Case Report : Medicine Log …

Background Human T-lymphotropic virus type 1 (HTLV-1) has been discovered in 1980 and
has been linked to tropical spastic paraparesis (HAM/TSP) in 1985 in Martinique. There is …

This study aimed to introduce clinical manifestations of patients in northeast Iran with HTLV-
1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and describe the …

Background High HTLV-1 proviral load (PVL) is mainly found in infected individuals with
HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). However one third …

The efficacy of long-term, high dose interferon-α (IFN-α) therapy was studied in seven
patients with HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP). IFN-α …

Human T-lymphotropic virus type 1 (HTLV-1) is classically associated with the HTLV-1-
associated myelopathy/tropical spastic paraparesis (HAM/TSP), although the mechanisms of …